Pharmaceutical Technology Europe, Sep 1, 2009 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Sep 1, 2009
The combination drugs debate: Incompatibility problems can be overcome
By Rajesh Dubey , Avvaru Seshasayana , Satti Phanikumar Reddy , Suryakumar Jayanthi
Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few.
The combination drugs debate: unstable and unpatentable
By Malcolm Ross
Combination products have been researched and administered for many years, some successfully and others not.
Is another ODT excipient necessary?
By H. Leonhard Ohrem , Roberto Ognibene
Parteck ODT is a newly introduced ready-to-use excipient for fast melt tablets.
The influence of superdisintegrant choice on the rate of drug dissolution
By Jagdish Balasubramaniam , Tim Bee
The addition of superdisintegrants to oral solid dosage forms can improve disintegration and, in turn, drug dissolution.
Embryonic stem cells: the moral dilemma of patentability and funding
By Beatriz San Martin
Human embryonic stem cells are of immense interest to researchers because of their ability to potentially develop into any kind of tissue.
The benefits of risk-based analyses during system validation
By Peter Woods , David Beale
When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.
Special Report
Belgium: Will its enviable geographic position continue to ensure success in pharma?
By Miyese Ozcan , Sam Joll , Mark Storry
Belgium is one of the largest centres for pharmaceutical distribution and has the second highest number of pharma exports per capita worldwide.
What to consider when expanding businesses into North America
By William C. Cairns , Gail Steckler
Increase your chances of success in the biggest market in the world.
Ask the Expert
Successful packaging of aseptically prefilled products
By Paul Nelles
Why correctly calibrating a drug with its packaging is the key to success.
Outsourcing Review
Expansion plan
By Jim Miller
In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.
A round up of news from across the globe.
Editor's Comment
Strength in numbers
By Fedra Pavlou
Merger, union, alliance, partnership, collaboration: five words that ultimately suggest the strengthening of something.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here